Author:
Finazzi T.,Rordorf T.,Ikenberg K.,Huber G. F.,Guckenberger M.,Garcia Schueler H. I.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference47 articles.
1. Hsu C, Lee S, Ejadi S. Antitumor activity and safety of pembrolizumab in patients with pd-l1-positive nasopharyngeal carcinoma: interim results from a phase 1b study. Vienna: European Cancer Congress; September 25–29; 2015. Abstract 2801
2. Suarez C, Rodrigo JP, Rinaldo A, et al. Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol. 2010;267:1811–24.
3. Chua DT, Sham JS, Leung LH, et al. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005;77:290–4.
4. Roeder F, Zwicker F, Saleh-Ebrahimi L, et al. Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Radiat Oncol. 2011;6:22.
5. Langendijk JA, Leemans CR, Buter J, et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004;22:4604–12.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献